PortfolioShield protects income traders the way the human body protects itself — a barrier that filters what enters, an immune system that responds to what's inside, and an adaptive memory that learns from every exposure.
They win 70% of their trades. They collect premium consistently. And year after year, they still lose money.
The trading industry sells tools to pick better trades. Nobody sells defense. There is no broker, no analytics platform, and no AI assistant that operates the way the human body does — anticipating threats before they enter, neutralizing them once they're inside, and remembering each one to fight it faster next time.
PortfolioShield is built on a structural claim: the income trader's portfolio is a living system under continuous attack. Treat it like one — or it dies.
Before any trade enters your portfolio, the Barrier checks if it fits — your current positions, your stated plan, your risk tolerance. The system never forbids the trade. You decide. But nothing enters by accident.
Like the skin or a cell membrane: physical filters that intercept threats before damage occurs. The proof of success is what didn't happen.
When a position becomes a zombie, when an assignment lands unexpectedly, when a loss is large enough to trigger revenge trading — the Immune System activates. It detects, responds, and contains the damage.
Like white blood cells responding to a pathogen: action after damage, but before catastrophe. Visible by design — you see the cooldown, the forced pause, the recovery plan.
Each trader has personal patterns of error. One closes too early on VIX spikes. Another increases size after three wins. Another rolls zombies instead of closing them. The Adaptive Memory recognizes these and warns before you repeat them.
It doesn't predict. It doesn't give advice. It surfaces evidence: "You've closed early during VIX spikes 4 times. 3 of 4 recovered within 8 days. Cost: $3,770." You still decide — but never in ignorance of your own history.
A cinematic exploration of the Portfolio Immune System — the biology, the architecture, the mechanics.
Join the early access cohort. Public launch in July.